Syntheses of compounds 1b, 2b, and 3b

7-Benzyl 1-methyl (2S,6R)-6-azido-2-tert-butoxycarbonylamino-heptanedioate (5). Diol
4
(4.2 g, 12 mmol) was dissolved in a mixed solvent system (50 mL of 2:2:3, CH 3 CN:CCl 4 :water) and treated sequentially with H 5 IO 6 (11 g, 48 mmol) and RuCl 3 (37 mg, 0.18 mmol). The resulting suspension was stirred for 2 h at RT, followed by sequential addition of CH 2 Cl 2 (50 mL) and water (50 mL). The layers were let to separate. The aqueous layer was washed with CH 2 Cl 2 , and the combined organic layers were dried over MgSO 4 . Evaporation of the solvents gave the crude acid, which was dissolved in DMF (50 mL), followed by the addition of benzyl bromide (2.8 mL, 22 mmol) and KHCO 3 (2.3 g, 23 mmol). The reaction mixture was stirred at RT for 16 h, diluted with diethyl ether and washed with water. The organic layer was dried (MgSO 4 ), filtered, and concentrated to dryness. The crude product was purified by silica gel column chromatography to obtain the benzyl ester 5 (2.5 g, 49% yield). 
Compound 8.
Compound 4 (9.6 g, 28 mmol) was dissolved in MeOH (60 mL) and treated with Ba(OH) 2 ·8H 2 O (8.7 g, 28 mmol). The resultant suspension was stirred for 4 h at RT.
Solvents were removed and the residue was taken up into EtOAc and water. The pH of the solution was adjusted to ~2 with 10% KHSO 4 in an ice-water bath. Layers were separated and the aqueous layer was washed with EtOAc. The combined organic layer was dried (MgSO 4 ), filtered, and concentrated to dryness. The crude acid was dissolved in CH 2 Cl 2 (100 mL), followed by the addition of 2-methoxypropene (5.0 mL, 52 mmol) and a catalytic amount of pyridinium p-toluenesulfonate (PPTS). The mixture was stirred at RT for 2 h before it was quenched with three drops of Et 3 N. The resulting solution was washed with brine, dried (MgSO 4 ), and concentrated. The crude acetonide was dissolved in DMF (50 mL) and was treated with N-hydroxysuccinimde (4.8 g, 42 mmol), followed by the addition of EDCI (8.1 g, 42 mmol) in an ice-water bath. The mixture was stirred at RT for 20 h.
-S3 -Meanwhile, the Boc-protected D-Ala-D-Ala-OBn (9.7 g, 28 mmol) in CH 2 Cl 2 (50 mL) was treated with trifluoroacetic acid (10 mL) in an ice-water bath. Temperature was gradually increased to RT over 1 h. The reaction mixture was evaporated to dryness under reduced pressure and the residue was dissolved in toluene (30 mL). This was followed by evaporation to dryness. The residue was dissolved in iPr 2 NEt (9.6 mL, 55 mmol) and DMF (10 mL), and the solution was then added to the NHS-ester of the tripeptide, as prepared above. The resulting mixture was stirred at RT for 20 h. The mixture was diluted with CH 2 Cl 2 and water was added.
Layers were separated. The organic layer was dried over MgSO 4 , filtered, concentrated and the sample was subjected to column chromatography on silica gel chromatography to obtain compound 8 as a white solid (8.7 g, 52% yield). The resultant oil was dissolved in anhydrous DMF (20 mL) and treated with iPr 2 NEt (1.6 mL, 9.0 mmol), followed by the addition of Boc-L-Ala--D-Glu(ONHS)-OBn (3.4 g, 4.6 mmol) in DMF (10 mL). The reaction mixture was stirred for 16 h at RT. The mixture was diluted with CH 2 Cl 2 and water. The separated organic layer was dried over MgSO 4 , filtered, concentrated and the sample was subjected to column chromatography on silica gel to give the title compound (1.6 g, 56% 
1-Methyl 7-(p-nitrobenzyl) (2S,6R)-6-azido-2-p-nitrophenylsulfonylaminoheptane-dioate (12).
Transformation of diol 4 to its p-nitrobenzyl ester was accomplished in the same manner as described for the preparation of 5, with the exception that p-nitrobenzyl bromide was used in place of benzyl bromide. The resulting compound (1-methyl 7-p-nitrobenzyl (2S,6R)-6-azido-2-tert-butoxycarbonylamino-heptanedioate, 0.40 g, 0.86 mmol) in CH 2 Cl 2 (2 mL) was treated with TFA (0.5 mL) in ice-water bath. The mixture was stirred for 30 min and ice-water bath was removed and stirring was continued for another 30 min. The reaction mixture was concentrated to dryness, 2 mL of toluene was added and the solution was evaportated to dryness again. The resultant oil was dissolved in CH 2 Cl 2 (5 mL) and was treated with iPr 2 NEt (0.45 mL, 2.6 mmol), followed by the addition of p-nitrophenyl sulfonyl chloride (0.29 g, 1.3 mmol). The solution was stirred at RT for 16 h. The mixture was diluted with CH 2 Cl 2 and water was added. The separated organic layer was dried over MgSO 4 , filtered, concentrated and the sample was subjected to column chromatography on silica gel to obtain the desired compound 12 as a white solid (0.30 g, 63% 
D-Ala-D-Ala-(14)--D-N-acetylglucosamine-(14)--D-N-acetylmuramyl-L-Ala--D-Glu-
meso-DAP-D-Ala-D-Ala (3b).
Compound 18 (0.50 g, 0.16 mmol) in AcOH (5 mL) was stirred at 60 ºC for 2 h. A portion of Pd/C (10%, 0.1 g) was added to the reaction mixture and was stirred under an atmosphere of hydrogen at 50 ºC for 3 h. The stirring was continued for an additional 2 h at RT. The reaction mixture was filtered through a layer of Celite. The combined filtrate was concentrated to dryness under reduced pressure. The crude product was subjected to HPLC purification to afford compound 3b (0.18 g, 56%). Preparative HPLC purifications were performed on delta-pak C18 reversed-phased column, 100 Å pore size, 19 × 300 mm using a linear gradient of 5-15% CH 3 CN in water supplemented with 0.1% TFA over 0.5 h. Compound 16. This material was prepared in the same manner as described for 18, with the exception that the protected muramyl derivative 13 was used in place of 15. Compound 17. This material was prepared in the same manner as described for 18, with the exception that the protected muramyl derivative 14 was used in place of 15. -S9 -
